🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Egg-derived trivalent subunit influenza vaccine (TIV)

Found 18 matching trials

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

PHASE3

This study will evaluate the safety and immunogenicity in healthy children ...

Status

Completed

Location

Centro de Atención e Investigación Medica - CAIMED

Start Date

2010-09

Trial ID

NCT01209780

Treatments Being Tested

TIV TIVf Comparator TIV

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

PHASE3

The present study will evaluate clinical efficacy, safety, tolerability and...

Status

Completed

Location

Site 14

Start Date

2007-10

Trial ID

NCT00630331

Treatments Being Tested

Cell culture-derived influenza vaccine Egg-derived influenza virus vaccine Placebo

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

PHASE3

The purpose of this study is to describe the immunogenicity and safety of t...

Status

Completed

Location

Multiple Locations

Start Date

2013-09

Trial ID

NCT02344134

Treatments Being Tested

NBP607 Agrippal S1

Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age

PHASE3

Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...

Status

Completed

Location

320, Novartis Investigational Site

Start Date

2013-05

Trial ID

NCT01857206

Treatments Being Tested

Mammalian cell based flu vaccine Egg based flu vaccine

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age

PHASE2

The present study is designed to confirm the safety and immunogenicity of t...

Status

Completed

Location

Antwerp University Centre for the Evaluation of Vaccination

Start Date

2013-07

Trial ID

NCT01879540

Treatments Being Tested

aTIV

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

PHASE3

This protocol is designed to evaluate safety, clinical tolerability and imm...

Status

Completed

Location

Site 2: C1425AWK

Start Date

2007-04

Trial ID

NCT00464672

Treatments Being Tested

Influenza virus vaccine Comparator influenza vaccine

Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

PHASE3

The study primarily aims to evaluate immunogenicity and safety of influenza...

Status

Completed

Location

Start Date

2007-10

Trial ID

NCT00579345

Treatments Being Tested

Cell culture derived seasonal trivalent influenza vaccine (cTIV)Influenza virus vaccine (egg-derived seasonal trivalent, thiomersal free; eTIV_a).cTIV or eTIV_a cTIV+PV OR eTIV_a+PV

A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications

PHASE3

The study is designed to evaluate the safety of TIVc or TIV vaccine in chil...

Status

Completed

Location

Novartis Investigational Site 022

Start Date

2013-10

Trial ID

NCT01998477

Treatments Being Tested

TIVc TIV

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

PHASE3

This phase 3 study is a randomized, double-blinded, comparator controlled, ...

Status

Completed

Location

Coastal Clinical Research, Inc.

Start Date

2017-10-17

Trial ID

NCT03314662

Treatments Being Tested

MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)Licensed MF59-adjuvanted Trivalent Subunit Inactivated Egg-derived Influenza Vaccine (aTIV-1)MF59-adjuvanted Trivalent Subunit Inactivated Egg-derived Influenza Vaccine Containing the Alternate B Strain (aTIV-2)

Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents

PHASE2

The present study is the first study designed to evaluate safety, tolerabil...

Status

Completed

Location

Site 09

Start Date

2007-10

Trial ID

NCT00645411

Treatments Being Tested

Cell culture-derived influenza subunit vaccine (cTIV)Egg derived influenza subunit vaccine (eTIV)Cell culture-derived influenza subunit vaccine (cTIV)Egg derived influenza subunit vaccine (eTIV)

Previous Next